4.6 Review

The Role of Antiviral Prophylaxis in Preventing HBV and HDV Recurrence in the Setting of Liver Transplantation

Related references

Note: Only part of the references are listed.
Article Gastroenterology & Hepatology

Use and outcomes of hepatitis B virus-positive grafts in orthotopic liver transplantation in the United States from 1999 to 2021

Saad Emhmed Ali et al.

Summary: Transplant recipients of HBV-positive liver allografts do not experience increased rates of mortality or graft loss compared to recipients of HBV-negative allografts. This provides a strategy for expanding the donor pool and reducing waitlist mortality rate.

LIVER TRANSPLANTATION (2023)

Article Gastroenterology & Hepatology

Safety and effectiveness of up to 3 years' bulevirtide monotherapy in patients with HDV-related cirrhosis

Alessandro Loglio et al.

Summary: This study describes the excellent virological and clinical responses in patients with HDV-related cirrhosis who had contraindications to interferon-based therapies when treated with BLV monotherapy for 3 years.

JOURNAL OF HEPATOLOGY (2022)

Review Gastroenterology & Hepatology

HBV-positive and HIV-positive organs in transplantation: A clinical guide for the hepatologist

Francesco Paolo Russo et al.

Summary: Organ transplantation is a life-saving treatment for patients with end-stage organ disease, but it is limited by a shortage of available organs. In recent years, there have been explorations and attempts to transplant organs from HBV and HIV positive donors in some countries. However, post-transplant antiviral therapies are necessary to prevent virus reactivation, and intentional virus transmission has practical, ethical, and clinical implications.

JOURNAL OF HEPATOLOGY (2022)

Article Microbiology

Efficacy and Safety of Bulevirtide plus Tenofovir Disoproxil Fumarate in Real-World Patients with Chronic Hepatitis B and D Co-Infection

Toni Herta et al.

Summary: The study analyzed real-life data of patients with chronic hepatitis delta treated with BLV and TDF, showing mostly positive virologic response after 24 weeks and sustained efficacy for more than 48 weeks.

PATHOGENS (2022)

Article Gastroenterology & Hepatology

Bulevirtide monotherapy for 48 weeks in patients with HDV-related compensated cirrhosis and clinically significant portal hypertension

Elisabetta Degasperi et al.

Summary: A 48-week course of BLV 2 mg/day monotherapy is safe and effective for patients with HDV-related compensated cirrhosis and CSPH.

JOURNAL OF HEPATOLOGY (2022)

Article Gastroenterology & Hepatology

Cost-Effectiveness of Utilization of Hepatitis B Virus-Positive Liver Donors for HBV-Negative Transplant Recipients

Tiffany C. Lee et al.

Summary: This study aimed to evaluate the cost-effectiveness of using HBV-infected donors for liver transplantation, and found that this strategy can be cost-effective in certain situations.

JOURNAL OF GASTROINTESTINAL SURGERY (2021)

Review Gastroenterology & Hepatology

2020 position statement and recommendations of the European Liver and Intestine Transplantation Association (ELITA): management of hepatitis B virus-related infection before and after liver transplantation

Christophe Duvoux et al.

Summary: ELITA has proposed recommendations for the prevention of HBV recurrence after liver transplantation, emphasizing personalized prophylaxis strategies based on risk assessment. Different prophylactic options are recommended for low and high virological risk patients, with specific considerations for special populations such as HDV, HCC, and poorly adherent patients. The recommendations aim to provide a more rational and standardized approach to HBV prophylaxis across liver transplant programs.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2021)

Article Gastroenterology & Hepatology

Hepatitis B Virus/Hepatitis D Virus-Coinfected Liver Transplant Candidate Receiving Hepatitis B Virus-Deoxyribonucleic Acid-Positive Allograft and Treated With High-Dose Hepatitis B Immune Globulin

Muhammad Baraa Hammami et al.

Summary: This case study discusses the liver transplantation of an HBV/HDV-coinfected recipient from an HBsAg-negative/HBV-deoxyribonucleic acid-positive deceased donor, along with treatment involving high-dose hepatitis B immune globulin and oral tenofovir alafenamide.

ACG CASE REPORTS JOURNAL (2021)

Article Surgery

OPTN/SRTR 2018 Annual Data Report: Liver

A. Kwong et al.

AMERICAN JOURNAL OF TRANSPLANTATION (2020)

Article Gastroenterology & Hepatology

Nucleoside analog monotherapy for prophylaxis in Hepatitis B liver transplant patients is safe and efficacious

Mark D. Muthiah et al.

HEPATOLOGY INTERNATIONAL (2020)

Article Gastroenterology & Hepatology

Liver transplantation using hepatitis B core positive grafts with antiviral monotherapy prophylaxis

Tiffany Cho-Lam Wong et al.

JOURNAL OF HEPATOLOGY (2019)

Review Gastroenterology & Hepatology

Management of chronic hepatitis B before and after liver transplantation

B. Wang et al.

FRONTLINE GASTROENTEROLOGY (2018)

Article Surgery

High Prevalence of Hepatitis B Nonimmunity in Vaccinated Pediatric Liver Transplant Recipients

D. H. Leung et al.

AMERICAN JOURNAL OF TRANSPLANTATION (2015)

Article Gastroenterology & Hepatology

The Global Burden of Liver Disease: The Major Impact of China

Fu-Sheng Wang et al.

HEPATOLOGY (2014)

Article Gastroenterology & Hepatology

Oral Nucleoside/Nucleotide Analogs Without Hepatitis B Immune Globulin After Liver Transplantation for Hepatitis B

James Fung et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2013)

Article Gastroenterology & Hepatology

Liver transplantation for HBV-related cirrhosis in Europe: An ELTR study on evolution and outcomes

Patrizia Burra et al.

JOURNAL OF HEPATOLOGY (2013)

Article Gastroenterology & Hepatology

Entecavir and hepatitis B immune globulin in patients undergoing liver transplantation for chronic hepatitis B

Robert Perrillo et al.

LIVER TRANSPLANTATION (2013)

Article Gastroenterology & Hepatology

Entecavir Monotherapy Is Effective in Suppressing Hepatitis B Virus After Liver Transplantation

James Fung et al.

GASTROENTEROLOGY (2011)

Review Gastroenterology & Hepatology

Liver grafts from anti-hepatitis B core positive donors: A systematic review

Evangelos Cholongitas et al.

JOURNAL OF HEPATOLOGY (2010)

Article Gastroenterology & Hepatology

Delta hepatitis: an update

P Farci

JOURNAL OF HEPATOLOGY (2003)